First iPS cell trial underway but a long way to go
This article was originally published in Scrip
Executive Summary
Researchers in Japan have "dosed" the initial patient in the world's first clinical trial involving a regenerative therapy based on the country's flagship induced pluripotent stem (iPS) cell technology.